Histopathological investigation of glioblastomas resected under bevacizumab treatment
Ryota Tamura(Keio University Hospital), Hikaru Sasaki(Tokyo Dental College Ichikawa General Hospital)
Cited by 55
Related Papers
Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis
|International Journal of Molecular Sciences|2021|231
The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications
|Medical Oncology|2019|219
Alterations of the tumor microenvironment in glioblastoma following radiation and temozolomide with or without bevacizumab
|Annals of Translational Medicine|2020|24
Gene therapy using genome‐edited <scp>iPS</scp> cells for targeting malignant glioma
|Bioengineering & Translational Medicine|2022|14